Colon Cancer Screening for Residents of Tampa, FL
Moffitt Cancer Center encourages Tampa, Florida, residents to be proactive about their colon health by making colon cancer screening part of their regular health care routine. Undergoing regular colon cancer screening is critical in the early detection and treatment of colon cancer for residents. Often, these screenings can detect clusters of abnormal tissue, called polyps, in a patient’s colon before their cancer has progressed to cause noticeable symptoms. When found early, polyps in the colon are often not yet malignant and can be removed before they undergo cancerous changes. Additionally, even when the polyps are cancerous, patients whose cancer is diagnosed early often have more treatment options available to them, therefore increasing their likelihood of achieving a favorable outcome.
Physicians commonly recommend that adults begin regular colon cancer screening once they reach 45 years of age. Younger individuals who are considered to be at a higher risk of developing colon cancer, however, should begin regular testing at a younger age. Risk factors for developing colon cancer include:
- Having a family history of the disease
- Being a colon cancer survivor
- Having specific inherited syndromes, like adenomatous polyposis or Lynch syndrome
- Having intestinal diseases, like ulcerative colitis and Crohn’s disease
At Moffitt Cancer Center in Tampa, we offer several screening options, like colonoscopies and high-sensitivity blood tests, to detect colon cancer in its earliest stages. In the event that a patient’s screening test shows precancerous or cancerous polyps, the experienced oncologists in our Gastrointestinal Oncology Program can develop an individualized treatment plan that will be most effective in treating the patient’s cancer.
If you live in the Tampa, FL, area and would like to speak with someone about colon cancer screening, call 1-888-663-3488 or submit a new patient registration form online. We do not require referrals.
Colon Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer